ZELIRA Trademark

Trademark Overview


On Thursday, January 9, 2020, a trademark application was filed for ZELIRA with the United States Patent and Trademark Office. The USPTO has given the ZELIRA trademark a serial number of 79280774. The federal status of this trademark filing is REGISTERED as of Tuesday, March 1, 2022. This trademark is owned by ZELIRA THERAPEUTICS LIMITED. The ZELIRA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Preparations for medical purposes derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, terminal illnesses, epilepsy, arthritis, crohn's disease, insomnia, diabetes, eczema, psychiatric diseases and disorders including mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder; none of the foregoing being preparations to treat deficiencies of Alpha-One proteinase inhibitors; none of the goods being for the treatment and detection of cervical cancer and related infections

Conducting clinical trials for others; research relating to science; provision of pharmaceutical research services; project management and planning of clinical trials, namely, consulting services for others in the field of design, planning, and implementation project management of clinical trials; research relating to pharmaceuticals; research relating to medicinal use of marijuana and cannabis; scientific research relating to medicinal use of cannabis; scientific research and development of medicinal cannabis products; medical research; scientific research for medical purposes; scientific research; none of the foregoing in relation to the treatment of deficiencies of Alpha-One proteinase inhibitors; none of the services being for the treatment and detection of cervical cancer and related infections
zelira

General Information


Serial Number79280774
Word MarkZELIRA
Filing DateThursday, January 9, 2020
Status700 - REGISTERED
Status DateTuesday, March 1, 2022
Registration Number6655611
Registration DateTuesday, March 1, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 14, 2021

Trademark Statements


Goods and ServicesPreparations for medical purposes derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, terminal illnesses, epilepsy, arthritis, crohn's disease, insomnia, diabetes, eczema, psychiatric diseases and disorders including mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder; none of the foregoing being preparations to treat deficiencies of Alpha-One proteinase inhibitors; none of the goods being for the treatment and detection of cervical cancer and related infections
Goods and ServicesConducting clinical trials for others; research relating to science; provision of pharmaceutical research services; project management and planning of clinical trials, namely, consulting services for others in the field of design, planning, and implementation project management of clinical trials; research relating to pharmaceuticals; research relating to medicinal use of marijuana and cannabis; scientific research relating to medicinal use of cannabis; scientific research and development of medicinal cannabis products; medical research; scientific research for medical purposes; scientific research; none of the foregoing in relation to the treatment of deficiencies of Alpha-One proteinase inhibitors; none of the services being for the treatment and detection of cervical cancer and related infections

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 16, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 16, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZELIRA THERAPEUTICS LIMITED
Party Type30 - Original Registrant
Legal Entity Type83 - NOT AVAILABLE
AddressAU

Party NameZELIRA THERAPEUTICS LIMITED
Party Type20 - Owner at Publication
Legal Entity Type83 - NOT AVAILABLE
AddressAU

Party NameZELIRA THERAPEUTICS LIMITED
Party Type10 - Original Applicant
Legal Entity Type83 - NOT AVAILABLE
AddressAU

Trademark Events


Event DateEvent Description
Monday, August 22, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, August 2, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, August 2, 2022FINAL DISPOSITION PROCESSED
Wednesday, June 1, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 1, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, February 2, 2022LIMITATION FROM THE IB EXAMINED AND ENTERED
Sunday, December 19, 2021NOTIFICATION PROCESSED BY IB
Tuesday, December 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 14, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 24, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 24, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, November 21, 2021LIMITATION OF GOODS RECEIVED FROM IB
Sunday, November 21, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, November 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 4, 2021SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Saturday, September 4, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, August 18, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 18, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, April 29, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, April 29, 2021LETTER OF SUSPENSION E-MAILED
Thursday, April 29, 2021SUSPENSION LETTER WRITTEN
Monday, April 19, 2021ATTORNEY REVIEW COMPLETED
Wednesday, March 24, 2021LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Tuesday, March 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 22, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 22, 2021LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Saturday, January 2, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, December 4, 2020LIMITATION OF GOODS RECEIVED FROM IB
Saturday, November 7, 2020LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, November 3, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 3, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 3, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 3, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 3, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, October 18, 2020REFUSAL PROCESSED BY IB
Thursday, September 24, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, September 24, 2020REFUSAL PROCESSED BY MPU
Wednesday, September 23, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 22, 2020NON-FINAL ACTION WRITTEN
Monday, September 14, 2020ASSIGNED TO EXAMINER
Sunday, March 29, 2020ASSIGNED TO EXAMINER
Friday, March 27, 2020ASSIGNED TO EXAMINER
Friday, March 20, 2020APPLICATION FILING RECEIPT MAILED
Monday, March 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 12, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB